Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FNMWF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,116
Award facts
- Contract value 100% obligated
- $12,115.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units) with a ceiling value of $12,115.65. This firm fixed-price delivery order, awarded on August 26, 2025, and due for completion by August 27, 2025, represents a product delivery under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA. The award carries no set-aside designation, reflecting the contractor's competitive position as a certified woman-owned small business in the federal pharmaceutical supply market.
DMS Pharmaceutical Group holds a significant single-award IDC with DLA valued at $499,999,999 through November 2026, which authorizes the issuance of delivery orders for a comprehensive portfolio of pharmaceutical products supporting military health facility requirements. This delivery order for Jakafi tablets exemplifies the contractor's role as a critical supplier within the federal pharmaceutical supply chain, providing prescription medications and pharmacy services to Department of Defense healthcare sites nationwide. Jakafi is a prescription medication used in the treatment of certain blood disorders, reflecting the contractor's specialty in providing both branded and generic prescription drugs to federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FNMWF?
SPE2DB25FNMWF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FNMWF worth?
The government has obligated $12,116 on SPE2DB25FNMWF.
Is contract SPE2DB25FNMWF an order under another contract?
Yes. SPE2DB25FNMWF is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMWF competed?
The extent of competition for SPE2DB25FNMWF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award